Top Page
Cann Group
(OTC:CAN)
Cann Group (CAN) vs. iShares MSCI Australia ETF (EWA)
Cann Group Business Overview & Revenue Model
Cann Group Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.25M | 13.25M | 15.37M | 13.78M | 6.41M | 4.29M |
| Gross Profit | -3.73M | 5.15M | -21.75M | 20.63M | 11.24M | 4.25M |
| EBITDA | -8.94M | -8.94M | -35.54M | -24.63M | -24.36M | -22.55M |
| Net Income | -22.34M | -22.34M | -51.24M | -33.79M | -26.47M | -25.10M |
Balance Sheet | ||||||
| Total Assets | 78.79M | 78.79M | 92.77M | 129.47M | 139.66M | 101.79M |
| Cash, Cash Equivalents and Short-Term Investments | 10.00K | 10.00K | 1.64M | 765.00K | 1.91M | 3.10M |
| Total Debt | 75.84M | 75.84M | 72.47M | 60.97M | 47.16M | 680.00K |
| Total Liabilities | 81.56M | 81.56M | 78.85M | 70.20M | 54.76M | 9.92M |
| Stockholders Equity | -2.77M | -2.77M | 13.92M | 59.26M | 84.90M | 91.87M |
Cash Flow | ||||||
| Free Cash Flow | -9.80M | -9.80M | -17.69M | -25.94M | -65.60M | -37.10M |
| Operating Cash Flow | -9.64M | -9.64M | -15.19M | -22.84M | -20.43M | -20.83M |
| Investing Cash Flow | -157.00K | -157.00K | 1.18M | -28.00K | -45.16M | -17.08M |
| Financing Cash Flow | 8.17M | 8.17M | 14.77M | 21.71M | 64.41M | 39.47M |
Cann Group Technical Analysis
Cann Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | AU$41.09M | 11.48 | 7.64% | 3.08% | 0.13% | -12.90% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
41 Neutral | AU$19.03M | -1.28 | ― | ― | -47.30% | 82.53% | |
40 Underperform | AU$12.44M | ― | -401.36% | ― | -26.49% | 61.72% | |
39 Underperform | AU$4.26M | 16.00 | ― | ― | 69.59% | ― | |
37 Underperform | $7.21M | ― | ― | ― | -15.81% | -358.33% |
Cann Group Corporate Events
Cann Group Limited has issued over 15 million fully paid ordinary shares to an Australian private credit fund to fulfill a capitalized interest payment, as previously outlined in their quarterly report. This move, approved by shareholders earlier in the year, signifies the company’s ongoing efforts to manage its financial obligations and maintain transparency with stakeholders, reflecting its commitment to regulatory compliance and strategic financial management.
Cann Group Limited has announced the issuance of over 15 million ordinary fully paid shares to a prominent Australian private credit fund. This move is intended to satisfy the payment of capitalized interest, as approved by shareholders during an Extraordinary General Meeting in May 2025. This strategic financial maneuver is expected to impact the company’s financial structure and enhance its market positioning by addressing its capital requirements.
Cann Group Limited announced an update to a previous announcement, correcting a clerical error regarding the issue price of placement shares. The price was initially listed as AUD 0.015 but has been corrected to AUD 0.0115. This adjustment ensures accurate financial reporting and may impact investor perceptions and the company’s market positioning.
Cann Group Limited has announced the quotation of 567,225,103 ordinary fully paid securities on the Australian Securities Exchange (ASX) as part of a previously announced transaction. This move is expected to enhance the company’s capital structure and provide additional resources to support its operations and strategic initiatives, potentially strengthening its position in the medicinal cannabis market.
Cann Group Limited has announced the quotation of 4,517,749 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of December 2, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially expand its market presence, reflecting a significant step in its growth and operational strategy.
Cann Group Limited announced a correction to the Appendix 3X for Mr. Mike Ryan, who was appointed as a Director effective 1 December 2025. The initial filing omitted Mr. Ryan’s relevant interest in 2,608,696 ordinary shares, which were part of a capital raise. The correction ensures compliance with listing rules and highlights the company’s commitment to transparency.
Cann Group Limited announced the successful results of its Annual General Meeting, where all resolutions were carried out through a poll. The meeting included the adoption of the remuneration report, re-election of a director, and approval of various share and option issuances. This outcome reflects strong shareholder support and positions the company to continue its strategic initiatives in the cannabis industry.
Cann Group Limited announced its upcoming Annual General Meeting, where the Chairman, Mr. Doug Rathbone, will address shareholders. The meeting is part of the company’s ongoing efforts to engage with stakeholders and provide updates on its operations and strategic direction. This announcement underscores Cann Group’s commitment to transparency and communication with its investors, which is crucial for maintaining its position in the competitive cannabis industry.
Cann Group Limited has announced the quotation of 127,597,050 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 24, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by improving access to capital and increasing shareholder value.
Cann Group Limited has announced an Extraordinary General Meeting (EGM) scheduled for December 23, 2025, to seek shareholder approval for several resolutions following a major refinancing transaction. This refinancing has significantly reduced the company’s debt from approximately $70 million to $15 million, providing essential funding for working and growth capital. The EGM will address the election of a new director and the approval of various options related to the capital raise, which includes issuing new shares and options to participants, including directors, as part of the company’s strategic financial restructuring.
Cann Group Limited has successfully raised $2.5 million through a Share Purchase Plan and Shortfall Placement, as part of a larger capital raising initiative that includes a $6.5 million institutional placement. The total funds of $9 million will be used to repay obligations to National Australia Bank, marking a significant milestone in the company’s debt restructuring program. This financial move is designed to strengthen Cann’s balance sheet, support financial sustainability, and enable the company to focus on its operational and commercial priorities.
Cann Group Limited has announced the closing of its Share Purchase Plan (SPP) Offer today, which allows eligible shareholders to purchase new shares at a discounted price. Each new share comes with an attaching option and a piggyback option, subject to shareholder approval at an upcoming extraordinary general meeting. The board appreciates the support from institutional investors and eligible shareholders, which reflects confidence in the company’s strategic direction and contributes to its growth.
Cann Group Limited has executed a forbearance and settlement deed with National Australia Bank, releasing the company from its existing loan obligations in exchange for a $15.30 million payment. This move is part of a broader debt restructuring strategy that includes securing new loans and raising capital through institutional placements and a share purchase plan. The restructuring is expected to strengthen Cann Group’s financial position and support its ongoing operations, potentially enhancing its market position and providing stability for stakeholders.
Cann Group Limited is hosting an investor update webinar on November 5, 2025, featuring CEO Jenni Pilcher and proposed incoming Chairman Mike Ryan. This event aims to engage shareholders and interested parties, allowing them to submit questions in advance, with a recording available post-session, reflecting the company’s commitment to transparency and stakeholder engagement.
Cann Group Limited has issued 120,395,238 fully paid ordinary shares as part of a tranche 1 placement at 1.15 cents per share. This move, executed under the company’s available placement capacity, aims to bolster its financial position and support its ongoing operations. The company has complied with all relevant disclosure obligations, ensuring transparency and adherence to regulatory requirements.
Cann Group Limited has announced a short-term extension of its debt facilities with National Australia Bank, moving the expiry date from October 31, 2025, to November 11, 2025. This extension is part of a forbearance and settlement agreement with NAB, which involves the release of all securities and closure of loan facilities upon a $15.30 million payment. The finalization of this agreement is expected by November 11, 2025, potentially impacting the company’s financial obligations and operational flexibility.
Cann Group Limited has opened its Share Purchase Plan (SPP) to eligible shareholders in Australia and New Zealand, allowing them to purchase up to $30,000 worth of new shares without transaction costs. This follows a successful private placement raising $6.5 million. The funds from these initiatives will be used to settle debt facilities with National Australia Bank. The company forecasts a 50% revenue growth in FY26, driven by strong demand for its products, and aims to achieve a positive EBITDA.
Cann Group Limited has announced a Share Purchase Plan (SPP) allowing eligible shareholders to purchase up to $30,000 of fully paid ordinary shares. This initiative is part of a broader capital raising effort, including a placement to institutional investors. The SPP aims to provide equitable participation opportunities, with scale-back arrangements applied on a pro rata basis. However, participation is restricted to residents of Australia and New Zealand, excluding other international shareholders.
Cann Group Limited has announced the quotation of 120,395,238 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 31, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and stakeholder interests positively.
Cann Group Limited has announced a Share Purchase Plan (SPP) allowing eligible shareholders to purchase up to $30,000 worth of new fully paid ordinary shares. This initiative, compliant with ASIC regulations, is part of the company’s strategy to raise capital and potentially enhance its market position by expanding its shareholder base. The SPP is set to open on 30 October 2025, with the company ensuring compliance with relevant corporate regulations and transparency requirements.
Cann Group Limited has announced its Annual General Meeting scheduled for November 28, 2025, where shareholders will discuss various resolutions including financial statements, director re-elections, and capital raising initiatives. The meeting will address key corporate matters such as the approval of remuneration reports, the issuance of placement shares, and amendments to the company’s constitution, which could have significant implications for the company’s strategic direction and stakeholder engagement.
Cann Group Limited has announced a capital raising initiative through the offer of new ordinary shares and options to sophisticated and professional investors. This move is aimed at strengthening the company’s financial position and supporting its growth strategy in the medicinal cannabis sector. The capital raising is expected to have a significant impact on Cann Group’s operations by providing the necessary funds to expand its market presence and enhance its industry positioning.
Cann Group Limited has announced a proposed issue of securities, including options and ordinary shares, as part of a securities purchase plan and placement. This move aims to raise capital, potentially strengthening the company’s financial position and supporting its growth initiatives in the medicinal cannabis sector.
Cann Group Limited has announced a significant restructuring of its debt and a capital raise, which includes a major debt forgiveness agreement with National Australia Bank, reducing its outstanding loan balance by 81%. The company has also secured a new loan from an existing lender and commitments for a $9 million capital raise through institutional placement and a share purchase plan. This financial restructuring is expected to improve Cann Group’s financial stability and market position, with projected revenue growth and a reduction in EBITDA losses by FY26.
Cann Group Limited has requested a trading halt on its securities pending an announcement related to its debt restructuring and capital raising activities. This move is intended to help the company manage its continuous disclosure obligations and is expected to have implications for its financial strategy and market positioning.
Cann Group Limited has announced a short-term extension of its debt facilities with National Australia Bank, moving the expiry date from 15 October 2025 to 31 October 2025. This extension allows the company additional time to engage in refinancing discussions and evaluate options that align with its long-term financial strategy, potentially impacting its operational stability and financial planning.
Cann Group Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement, approved by the board, outlines the company’s adherence to ASX Corporate Governance Council’s principles and recommendations. This announcement underscores Cann Group’s commitment to transparency and accountability, potentially strengthening its position in the market and providing reassurance to stakeholders regarding its governance practices.
Cann Group Limited has announced a new issuance of 28,414,222 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) as of September 26, 2025. This move is part of the company’s strategic efforts to enhance its capital structure and support its ongoing operations and growth initiatives in the medicinal cannabis sector.
Cann Group Limited has announced the quotation of 11,546,780 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 25, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially increase its market presence, which could have implications for its operations and stakeholders by providing additional resources for growth and development.
Cann Group Limited announced a positive EBITDA for August 2025, marking a significant milestone since the commissioning of its Mildura facility in 2022. The company’s growth is driven by strong B2B flower sales, expansion of its Botanitech product range, and increasing export opportunities, particularly in Europe. Cann is also enhancing its product portfolio with new offerings and has secured additional R&D funding, while progressing its refinancing initiatives to support future growth.
Cann Group Limited has received a Letter of Non-Waiver from National Australia Bank regarding its non-payment of interest and facility fees totaling $1,378,152, which were due in late August 2025. While NAB reserves its rights, it has decided not to take any action at this time. Cann Group is actively engaging with NAB and other financiers to address its financing arrangements and plans to update the market by the end of September 2025.